Wenwen Zhang

10PUBLICATIONS
8CO-AUTHORS
Nanotoxicology, health and safetyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 13, 2026
Correction to "Enrichment and Detection of HER2-Expressing Extracellular Vesicles Based on DNA Tetrahedral Nanostructures: A New Strategy for Liquid Biopsy in Breast Cancer".

Feng Xu, Ke Wang, Chi Xu

|Mar 21, 2025
Enrichment and Detection of HER2-Expressing Extracellular Vesicles Based on DNA Tetrahedral Nanostructures: A New Strategy for Liquid Biopsy in Breast Cancer.

Feng Xu, Ke Wang, Chi Xu

|Jan 01, 2025
Antibody-drug conjugates in breast cancer.

Yinxing Zhu, Yaqi Song, Xilei Zhou

|Jun 27, 2023
Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.

Yinxing Zhu, Yixuan Hu, Junfeng Shi

|May 04, 2023
Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.

Yixuan Hu, Yinxing Zhu, Weiwei Nie

|Oct 27, 2022
Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile.

Chengjun Zhu, Jing Xu, Jinyu Sun

Pageof 2

Frequent Collaborators

3 joint publications

Xiaoxiang Guan

2 joint publications

Zhe Li

1 joint publications

Chengjun Zhu

1 joint publications

Jinyu Sun